論文: Drug Discovery & Development
The article explores how using biosimulation for rare disease drug development can help overcome challenges in traditional clinical trials. Experts from Certara- Drs. Rajesh Krishna and Oxana Iliach, highlight how these technologies can be used to enhance statistical precision, create virtual cohorts, simulate control arms, and optimize trial designs. The discussion also covers policy changes and collaborative frameworks to boost accessibility and development in the rare disease space.
Published: 2025年3月14日
Learn more about Rare and Neglected Diseases
サターラの統合ソリューションで、希少疾患治療薬開発を根本から進化させましょう。前臨床の知見から市場参入戦略まで、あらゆる開発段階をリードする卓越した専門性をご提供します。
